HighVista Strategies’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

HighVista Strategies’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-40,612	Closed	-$578K	–	103
2021 Q4	$578K	Buy	40,612 +13,901	+52%	+$241K	0.46%	62
2021 Q3	$619K	Sell	26,711 -1,974	-7%	-$46.7K	0.41%	68
2021 Q2	$714K	Buy	28,685 +8,055	+39%	+$216K	0.51%	62
2021 Q1	$578K	Buy	20,630 +2,378	+13%	+$85.8K	0.43%	62
2020 Q4	$637K	Buy	18,252 +5,927	+48%	+$258K	0.41%	61
2020 Q3	$614K	Buy	+12,325	New	+$498K	0.45%	27

Other funds holding FMTX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HighVista Strategies's FMTX Position: Q1 2022 in Review

HighVista Strategies sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q1 2022, closing a stake of 40,612 shares — an estimated $578K sold.

HighVista Strategies first reported a position in FMTX in Q3 2020 and held it in 6 quarters. The position peaked at $714K in Q2 2021. 98 funds tracked by Wall St. Rank hold FMTX as of Q1 2022.

HighVista Strategies reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
HighVista Strategies sold 40,612 Forma Therapeutics Holdings, Inc. Common Stock shares in Q1 2022, an estimated $578K.
HighVista Strategies first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2020 and held it in 6 quarters.
HighVista Strategies's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $714K in Q2 2021.
98 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q1 2022.

Based on HighVista Strategies's 13F filing for Q1 2022, filed 16 May 2022.